Literature DB >> 10570044

Molecular and functional characterization of human P2X(2) receptors.

K J Lynch1, E Touma, W Niforatos, K L Kage, E C Burgard, T van Biesen, E A Kowaluk, M F Jarvis.   

Abstract

P2X receptors are a family of ATP-gated ion channels. Four cDNAs with a high degree of homology to the rat P2X(2) receptor were isolated from human pituitary and pancreas RNA. Genomic sequence indicated that these cDNAs represent alternatively spliced messages. Northern analysis revealed high levels of human P2X(2) (hP2X(2)) message in the pancreas, and splice variants could be detected in a variety of tissues. Two cDNAs encoded functional ion channels when expressed in Xenopus oocytes, a receptor structurally homologous to the prototype rat P2X(2) receptor (called hP2X(2a)) and a variant containing a deletion within its cytoplasmic C terminus (called hP2X(2b)). Pharmacologically, these functional human P2X(2) receptors were virtually indistinguishable, with the P2X receptor agonists ATP, 2-methylthio-ATP, 2' and 3'-O-(4-benzoylbenzoyl)-ATP, and ATP5'-O-(3-thiotriphosphate) being approximately equipotent (EC(50) = 1 microM) in eliciting extracellular Ca(2+) influx. The P2 receptor agonists alpha,beta-methylene ATP, adenosine, adenosine 5'-O-(2-thiodiphosphate), and UTP were inactive at concentrations up to 100 microM. Both hP2X(2a) and hP2X(2b) receptors were sensitive to the P2 receptor antagonist pyridoxal-5-phosphate-6-azophenyl-2', 4'-disulfonic acid (IC(50) = 3 microM). In contrast to the analogous rat P2X(2) and P2X(2b) receptors, the desensitization rates of the hP2X(2a) and hP2X(2b) receptors were equivalent. Both functional forms of the human P2X(2) receptors formed heteromeric channels with the human P2X(3) receptor. These data demonstrate that the gene structure and mRNA heterogeneity of the P2X(2) receptor subtype are evolutionarily conserved between rat and human, but also suggest that alternative splicing serves a function other than regulating the desensitization rate of the human receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570044     DOI: 10.1124/mol.56.6.1171

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

1.  2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.

Authors:  Torben R Neelands; Edward C Burgard; Marie E Uchic; Heath A McDonald; Wende Niforatos; Connie R Faltynek; Kevin J Lynch; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

Review 2.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 3.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 4.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

5.  Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space.

Authors:  C H Mitchell
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

6.  Functional relevance of aromatic residues in the first transmembrane domain of P2X receptors.

Authors:  Marie Jindrichova; Vojtech Vavra; Tomas Obsil; Stanko S Stojilkovic; Hana Zemkova
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

7.  A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.

Authors:  Michael F Jarvis; Edward C Burgard; Steve McGaraughty; Prisca Honore; Kevin Lynch; Timothy J Brennan; Alberto Subieta; Tim Van Biesen; Jayne Cartmell; Bruce Bianchi; Wende Niforatos; Karen Kage; Haixia Yu; Joe Mikusa; Carol T Wismer; Chang Z Zhu; Katharine Chu; Chih-Hung Lee; Andrew O Stewart; James Polakowski; Bryan F Cox; Elizabeth Kowaluk; Michael Williams; James Sullivan; Connie Faltynek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

Review 8.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

9.  Curating Clinically Relevant Transcripts for the Interpretation of Sequence Variants.

Authors:  Marina T DiStefano; Sarah E Hemphill; Brandon J Cushman; Mark J Bowser; Elizabeth Hynes; Andrew R Grant; Rebecca K Siegert; Andrea M Oza; Michael A Gonzalez; Sami S Amr; Heidi L Rehm; Ahmad N Abou Tayoun
Journal:  J Mol Diagn       Date:  2018-08-08       Impact factor: 5.568

10.  Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function.

Authors:  Chengqun Sun; Jessica Chu; Sarita Singh; Russell D Salter
Journal:  Purinergic Signal       Date:  2009-10-17       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.